Hello all,
I thought some of you who aren't invested in MLSC might want to hear some of the contents of MLSC recent shareholder's letter, so over the next couple of days I will post the noteworth stuff. It is a six page letter, so I may condense it here and there, and so as not to appear to plagiarize, please allow me to do some nip and tuck on some of the repetitive stuff without penalizing me. Also, I'm not a typist by profession, so please pardon typo's. Most all of the following will be verbatim from the shareholder's letter.
Lee Kulas began his letter asserting his strategy to "transform MLSC from a developmental company into a world class medical technology development corporation capable of introducing a new generation of anti-bacterial, anti-viral and anti-fungal pharmaceuticials and related products." He then elaborated on the recent developments in areas of technological improvments, business development and strategic alliances that have enabled MDI to quickly enter new markets which will bring reveneue producing opportunities in the short term.
Technological Improvements:
In early August, the combined efforts of our research and development teams, both here and in Japan, our business development group and our patent attorneys led to the development of a major breakthrough in our core technologies, and have opened up a wide variety of new business opportunities.
Whereas before, our core technology resulted in single electrically hydrolized saline solution ("functional water") which was primarily focused in the areas of therapeutic pharmaceutical applications and medical products sterilization, our latest technological achievments have provided MLSC with the capability to produce a wide variety of electrically hydrolized saline solutions ("functional waters") which have applications in an ever increasing number of new markets. Among these new markets are the following: cosmetic skin care; hydrotherapy; environmental decontamination and water purification.
While Medical Discoveries now functions as a world-wide cohesive team, I want to specifically congratulate the following individuals for their ingenuity, creativity and tireless efforts which created our latest technological breakthrough: Dan Robinson, Principal Inventor and Systems Design Engineer; Paul Griesgraber, Director of Licensing and Development and Dr. William J. Novick, Ph.D., Chief Technical officer.
Strategic Alliances (United States)
In late September, Medical Discoveries began discussions both here in the U.S. and in Japan with several companies actively involved in the "functional water" business to assess the possibilities for mutual cooperation and strategic alliance. Our interest in this endeavor was to bring critical mass to Medical Discoveries and improve it's technical and marketing capabilities, and also enable Medical Discoveries to enter revenue producing markets in the near term. In the U.S. a privately held, San Francisco based company, Advanced H2O, and it's principal, Mr Edward Alexander, has been actively involved in the research, development and commercialization of systems used for water purification in both the home and in industrial markets. Mr Alexander has been a pioneer in this country in the investigation of applications for "functional waters", and has been successful in introducing different systems from Japan into the U.S. markets.
To a great extent, Ed ALexander has independantly shared the same vision as Medical Discoveries in developing and promoting the benefits of "functional waters" for humankind. While Medical Discoveries' efforts have been primarily focused on medical and therapeutic applications, Advanced H20 has concentrated in many other, non-medical markets, including water purification, environmental decontamination, hydrotherapy and the commercialization of bottled waters.
Ed's vision and in-depth experience and expertise in the international arena of "functional waters" development is unsurpassed, and has enabled Ed and Advanced H20 to take a leadership role in this emerging technology. It was for these reasons that we sought to explore opportunitues to align our efforts and merge our mutual capabilities.
I am pleased to announce that effective November 1 1997, Medical Discoveries, Inc. and Advanced H20 have agreed in principle to merge their business activities in the fields of "functional waters". Ed ALexander has joined us as Vice President, and will serve on Medical Discoveries Board of Directors. Under Ed's leadership and guidance, this merger between Medical Discoveries and Advanced H20 enables us to effectively and efficiently enter non-medical markets using combinations of our new technologies and other products.
More tomorrow...
Cindy |
